EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Novel Ferroptosis-Related Gene Prognosis Signature and Identifying Atorvastatin as a Potential Therapeutic Agent for Hepatocellular Carcinoma

Ling Wang iD, Xiaoqin He, Yang Shen iD, Jiayu Chen, Yukai Chen, Zhuolin Zhou iD, Ximing Xu

Current Issues in Molecular Biology · 18.03.2025 · 47 (3) · 201

DOI: 10.3390/cimb47030201 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Issues in Molecular Biology, online erschienen am 18.03.2025. Verfasst von Ling Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Center, Renmin Hospital of Wuhan University, Wuhan 430060, China. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Among the most common malignant tumors, hepatocellular carcinoma (HCC) is a primary liver cancer type that has a high mortality rate. HCC often presents insidiously, is prone to recurrence, and has limited treatment efficacy. Ferroptosis regulates tumorigenesis, progression, and metastasis, which is a novel form of iron-dependent cell death. Numerous studies suggest that HCC is sensitive to ferroptosis, indicating that targeted therapies aimed at inducing ferroptosis may represent a promising new approach to cancer treatment. This study aims to find genes associated with HCC and ferroptosis, as well as to screen for potential agents that may cause ferroptosis in HCC. Transcriptome and clinical sample data were obtained from the TCGA database to identify differentially expressed genes related to ferroptosis. Using various regression and survival analysis techniques, we developed a prognostic model based on four core genes and evaluated its predictive potential. Subsequently, we screened for potential therapeutic agents in the Connective Map (CMap) database, designated as compound Atorvastatin, based on differential genes from two risk groups and related to ferroptosis. Through experiments conducted in vivo and in vitro, we demonstrated that Atorvastatin can induce ferroptosis in HCC cells while inhibiting their growth and migration. In conclusion, this research targets ferroptosis therapy and provides new insights for improving the prediction and prevention of HCC.

Schlagwörter

Stichwörter der Autor:innen

CMap databaseFRG signatureantitumor drugferroptosishepatocellular carcinomaprognosis

Autor:innen und Institutionen

  • Cancer Center, Renmin Hospital of Wuhan University, Wuhan 430060, China.

ORCID-Profile: Ling Wang, Yang Shen, Zhuolin Zhou

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Wang, L., He, X., Shen, Y., Chen, J., Chen, Y., Zhou, Z., & Xu, X. (2025). A Novel Ferroptosis-Related Gene Prognosis Signature and Identifying Atorvastatin as a Potential Therapeutic Agent for Hepatocellular Carcinoma. Current Issues in Molecular Biology, 47(3), 201. https://doi.org/10.3390/cimb47030201

Vancouver

Wang L, He X, Shen Y, Chen J, Chen Y, Zhou Z, et al. A Novel Ferroptosis-Related Gene Prognosis Signature and Identifying Atorvastatin as a Potential Therapeutic Agent for Hepatocellular Carcinoma. Current Issues in Molecular Biology. 2025;47(3):201. doi:10.3390/cimb47030201

BibTeX
@article{Wang2025,
  author = {Wang, Ling and He, Xiaoqin and Shen, Yang and Chen, Jiayu and Chen, Yukai and Zhou, Zhuolin and Xu, Ximing},
  title = {A Novel Ferroptosis-Related Gene Prognosis Signature and Identifying Atorvastatin as a Potential Therapeutic Agent for Hepatocellular Carcinoma},
  journal = {Current Issues in Molecular Biology},
  year = {2025},
  volume = {47},
  number = {3},
  pages = {201},
  doi = {10.3390/cimb47030201}
}
Kostenlos starten →